InspireMD (NSPR) Competitors

InspireMD (NYSE:NSPR) and GBS (NYSE:GBS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Do analysts prefer NSPR or GBS?

InspireMD presently has a consensus target price of $4.85, indicating a potential upside of 128.77%. Given InspireMD's higher possible upside, analysts plainly believe InspireMD is more favorable than GBS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
GBS	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has preferable earnings & valuation, NSPR or GBS?

GBS has lower revenue, but higher earnings than InspireMD. GBS is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$6.21M	8.01	-$19.92M	-$1.08	-1.96
GBS	$440K	94.75	-$8.31M	-$0.56	-5.00

Is NSPR or GBS more profitable?

GBS has a net margin of 0.00% compared to InspireMD's net margin of -320.97%. InspireMD's return on equity of -55.71% beat GBS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-320.97%	-55.71%	-46.53%
GBS	N/A	-85.64%	-54.42%

Do insiders and institutionals believe in NSPR or GBS?

44.8% of InspireMD shares are held by institutional investors. Comparatively, 2.8% of GBS shares are held by institutional investors. 21.6% of InspireMD shares are held by company insiders. Comparatively, 0.3% of GBS shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the media refer more to NSPR or GBS?

In the previous week, GBS had 8 more articles in the media than InspireMD. MarketBeat recorded 9 mentions for GBS and 1 mentions for InspireMD. InspireMD's average media sentiment score of 0.59 beat GBS's score of 0.35 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GBS	2 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in NSPR or GBS?

InspireMD received 2 more outperform votes than GBS when rated by MarketBeat users.

Company	Underperform	Outperform
InspireMD	Outperform Votes 2 4.08%	Underperform Votes 47 95.92%
GBS	N/A	N/A

Which has more risk and volatility, NSPR or GBS?

InspireMD has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, GBS has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500.

Summary

InspireMD beats GBS on 10 of the 16 factors compared between the two stocks.